Table 1. Candida Infections Drugs Market Size & CAGR: China VS Global, 2019-2030, US$ Million

Table 2. Candida Infections Drugs Market Restraints

Table 3. Candida Infections Drugs Market Trends

Table 4. Candida Infections Drugs Industry Policy

Table 5. Global Candida Infections Drugs Revenue by Company, 2019-2024, US$ million

Table 6. Global Candida Infections Drugs Revenue Market Share by Company, 2019-2024

Table 7. Global Candida Infections Drugs Sales Volume by Company, 2019-2024, (K Units)

Table 8. Global Candida Infections Drugs Sales Volume Market Share by Company, 2019-2024

Table 9. Global Candida Infections Drugs Price by Company, 2019-2024, (US$/Unit)

Table 10. Global Candida Infections Drugs Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Candida Infections Drugs Mergers & Acquisitions, Expansion Plans

Table 12. Global Candida Infections Drugs Manufacturers Product Type

Table 13. China Candida Infections Drugs Revenue by Company, 2019-2024, US$ million

Table 14. China Candida Infections Drugs Revenue Market Share by Company, 2019-2024

Table 15. China Candida Infections Drugs Sales Volume by Company, 2019-2024, (K Units)

Table 16. China Candida Infections Drugs Sales Volume Market Share by Company, 2019-2024

Table 17. China Market, Candida Infections Drugs Production, Sales, Import and Export, 2019-2030, (K Units)

Table 18. China Candida Infections Drugs Import & Export Trends

Table 19. Main Sources of China Candida Infections Drugs Import

Table 20. Export Destination of China Candida Infections Drugs

Table 21. Global Headquarters and Manufacturing Base of Candida Infections Drugs Manufacturers

Table 22. Global Major Manufacturers, Candida Infections Drugs Capacity Expansion and Future Plans

Table 23. Global Candida Infections Drugs Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)

Table 24. Global Candida Infections Drugs Production by Region, 2019-2024, (K Units)

Table 25. Global Candida Infections Drugs Production Forecast by Region, 2024-2030, (K Units)

Table 26. Global Key Players of Candida Infections Drugs Upstream (Raw Materials)

Table 27. Global Candida Infections Drugs Typical Customers

Table 28. Candida Infections Drugs Typical Distributors

Table 29. By Type, Global Candida Infections Drugs Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 30. By Application, Global Candida Infections Drugs Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 31. By Region, Global Candida Infections Drugs Market Size, 2019 VS 2024 VS 2030, US$ Million

Table 32. By Region, Global Candida Infections Drugs Revenue, 2019-2030, US$ Million

Table 33. By Region, Global Candida Infections Drugs Sales Volume, 2019-2030, (K Units)

Table 34. By Country, Global Candida Infections Drugs Revenue & CAGR，2019 VS 2024 VS 2030, US$ Million

Table 35. By Country, Global Candida Infections Drugs Revenue, 2019-2030, US$ Million

Table 36. By Country, Global Candida Infections Drugs Revenue Market Share, 2019-2030

Table 37. By Country, Global Candida Infections Drugs Sales Volume, 2019-2030, (K Units)

Table 38. By Country, Global Candida Infections Drugs Sales Volume Market Share, 2019-2030

Table 39. F. Hoffmann-La Roche Ltd Company Information, Head Office, Market Area and Industry Position

Table 40. F. Hoffmann-La Roche Ltd Candida Infections Drugs Models, Specifications and Application

Table 41. F. Hoffmann-La Roche Ltd Candida Infections Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 42. F. Hoffmann-La Roche Ltd Company Profile and Main Business

Table 43. F. Hoffmann-La Roche Ltd Recent Developments

Table 44. Mylan NV Company Information, Head Office, Market Area and Industry Position

Table 45. Mylan NV Candida Infections Drugs Models, Specifications and Application

Table 46. Mylan NV Candida Infections Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 47. Mylan NV Company Profile and Main Business

Table 48. Mylan NV Recent Developments

Table 49. Teva Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position

Table 50. Teva Pharmaceutical Industries Ltd Candida Infections Drugs Models, Specifications and Application

Table 51. Teva Pharmaceutical Industries Ltd Candida Infections Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 52. Teva Pharmaceutical Industries Ltd Company Profile and Main Business

Table 53. Teva Pharmaceutical Industries Ltd Recent Developments

Table 54. Sanofi Company Information, Head Office, Market Area and Industry Position

Table 55. Sanofi Candida Infections Drugs Models, Specifications and Application

Table 56. Sanofi Candida Infections Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 57. Sanofi Company Profile and Main Business

Table 58. Sanofi Recent Developments

Table 59. Pfizer Inc Company Information, Head Office, Market Area and Industry Position

Table 60. Pfizer Inc Candida Infections Drugs Models, Specifications and Application

Table 61. Pfizer Inc Candida Infections Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 62. Pfizer Inc Company Profile and Main Business

Table 63. Pfizer Inc Recent Developments

Table 64. GSK plc Company Information, Head Office, Market Area and Industry Position

Table 65. GSK plc Candida Infections Drugs Models, Specifications and Application

Table 66. GSK plc Candida Infections Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 67. GSK plc Company Profile and Main Business

Table 68. GSK plc Recent Developments

Table 69. Novartis AG Company Information, Head Office, Market Area and Industry Position

Table 70. Novartis AG Candida Infections Drugs Models, Specifications and Application

Table 71. Novartis AG Candida Infections Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 72. Novartis AG Company Profile and Main Business

Table 73. Novartis AG Recent Developments

Table 74. AstraZeneca Company Information, Head Office, Market Area and Industry Position

Table 75. AstraZeneca Candida Infections Drugs Models, Specifications and Application

Table 76. AstraZeneca Candida Infections Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 77. AstraZeneca Company Profile and Main Business

Table 78. AstraZeneca Recent Developments

Table 79. Johnson & Johnson Private Limited Company Information, Head Office, Market Area and Industry Position

Table 80. Johnson & Johnson Private Limited Candida Infections Drugs Models, Specifications and Application

Table 81. Johnson & Johnson Private Limited Candida Infections Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 82. Johnson & Johnson Private Limited Company Profile and Main Business

Table 83. Johnson & Johnson Private Limited Recent Developments

Table 84. Sun Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position

Table 85. Sun Pharmaceutical Industries Ltd Candida Infections Drugs Models, Specifications and Application

Table 86. Sun Pharmaceutical Industries Ltd Candida Infections Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 87. Sun Pharmaceutical Industries Ltd Company Profile and Main Business

Table 88. Sun Pharmaceutical Industries Ltd Recent Developments

Table 89. Merck & Co., Inc Company Information, Head Office, Market Area and Industry Position

Table 90. Merck & Co., Inc Candida Infections Drugs Models, Specifications and Application

Table 91. Merck & Co., Inc Candida Infections Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 92. Merck & Co., Inc Company Profile and Main Business

Table 93. Merck & Co., Inc Recent Developments

Table 94. Bristol-Myers Squibb Company Company Information, Head Office, Market Area and Industry Position

Table 95. Bristol-Myers Squibb Company Candida Infections Drugs Models, Specifications and Application

Table 96. Bristol-Myers Squibb Company Candida Infections Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 97. Bristol-Myers Squibb Company Company Profile and Main Business

Table 98. Bristol-Myers Squibb Company Recent Developments

Table 99. Lilly Company Information, Head Office, Market Area and Industry Position

Table 100. Lilly Candida Infections Drugs Models, Specifications and Application

Table 101. Lilly Candida Infections Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 102. Lilly Company Profile and Main Business

Table 103. Lilly Recent Developments

Table 104. Amgen Inc Company Information, Head Office, Market Area and Industry Position

Table 105. Amgen Inc Candida Infections Drugs Models, Specifications and Application

Table 106. Amgen Inc Candida Infections Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 107. Amgen Inc Company Profile and Main Business

Table 108. Amgen Inc Recent Developments

List of Figure

Figure 1. Candida Infections Drugs Picture

Figure 2. By Revenue, Global Candida Infections Drugs Market Size and Forecast, 2019-2030, US$ Million

Figure 3. By Sales Volume, Global Candida Infections Drugs Market Size and Forecast, 2019-2030, (K Units)

Figure 4. Global Candida Infections Drugs Price Trend, 2019-2030, (US$/Unit)

Figure 5. By Revenue, China Candida Infections Drugs Market Size and Forecast, 2019-2030, US$ million

Figure 6. By Sales Volume, China Candida Infections Drugs Market Size and Forecast, 2019-2030, (K Units)

Figure 7. China Candida Infections Drugs Price Trend, 2019-2030 (US$/Unit)

Figure 8. By Revenue, China Candida Infections Drugs Share of Global Market, 2019-2030

Figure 9. By Sales Volume, China Candida Infections Drugs Share of Global Market, 2019-2030

Figure 10. Global Candida Infections Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 11. Global Candida Infections Drugs Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022

Figure 12. China Candida Infections Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 13. China Candida Infections Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 14. China Candida Infections Drugs Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024

Figure 15. Chinese Local Players, Proportion of Candida Infections Drugs Domestic VS Export, 2022

Figure 16. Global Candida Infections Drugs Capacity, Production and Capacity Utilization, 2019-2030

Figure 17. Global Candida Infections Drugs Capacity Market Share by Region, 2022 VS 2029

Figure 18. Global Candida Infections Drugs Production Market Share & Forecast by Region, 2019-2030

Figure 19. Candida Infections Drugs Industry Chain

Figure 20. Candida Infections Drugs Procurement Model

Figure 21. Candida Infections Drugs Sales Model

Figure 22. Candida Infections Drugs Sales Channels, Direct Sales and Distribution

Figure 23. Azole

Figure 24. Nystatin

Figure 25. Other

Figure 26. By Type, Global Candida Infections Drugs Revenue, 2019-2030, US$ Million

Figure 27. By Type, Global Candida Infections Drugs Revenue Market Share, 2019-2030

Figure 28. By Type, Global Candida Infections Drugs Sales Volume, 2019-2030, (K Units)

Figure 29. By Type, Global Candida Infections Drugs Sales Volume Market Share, 2019-2030

Figure 30. By Type, Global Candida Infections Drugs Price, 2019-2030, (US$/Unit)

Figure 31. Beriberi

Figure 32. Jock Itch

Figure 33. Vaginal Infection

Figure 34. Other

Figure 35. By Application, Global Candida Infections Drugs Revenue, 2019-2030, US$ Million

Figure 36. By Application, Global Candida Infections Drugs Revenue Market Share, 2019-2030

Figure 37. By Application, Global Candida Infections Drugs Sales Volume, 2019-2030, (K Units)

Figure 38. By Application, Global Candida Infections Drugs Sales Volume Market Share, 2019-2030

Figure 39. By Application, Global Candida Infections Drugs Price, 2019-2030, (US$/Unit)

Figure 40. By Region, Global Candida Infections Drugs Revenue Market Share, 2019-2030

Figure 41. By Region, Global Candida Infections Drugs Sales Volume Market Share, 2019-2030

Figure 42. North America Candida Infections Drugs Revenue & Forecasts, 2019-2030, US$ Million

Figure 43. By Country, North America Candida Infections Drugs Revenue Market Share, 2022

Figure 44. Europe Candida Infections Drugs Revenue & Forecasts, 2019-2030, US$ Million

Figure 45. By Country, Europe Candida Infections Drugs Revenue Market Share, 2022

Figure 46. Asia Pacific Candida Infections Drugs Revenue & Forecasts, 2019-2030, US$ Million

Figure 47. By Country/Region, Asia Pacific Candida Infections Drugs Revenue Market Share, 2022

Figure 48. South America Candida Infections Drugs Revenue & Forecasts, 2019-2030, US$ Million

Figure 49. By Country, South America Candida Infections Drugs Revenue Market Share, 2022

Figure 50. Middle East & Africa Candida Infections Drugs Revenue & Forecasts, 2019-2030, US$ Million

Figure 51. U.S. Candida Infections Drugs Sales Volume, 2019-2030, (K Units)

Figure 52. By Company, U.S. Candida Infections Drugs Market Share, 2022

Figure 53. By Type, U.S. Candida Infections Drugs Sales Volume Market Share, 2022 VS 2029

Figure 54. By Application, U.S. Candida Infections Drugs Sales Volume Market Share, 2022 VS 2029

Figure 55. Europe Candida Infections Drugs Sales Volume, 2019-2030, (K Units)

Figure 56. By Company, Europe Candida Infections Drugs Market Share, 2022

Figure 57. By Type, Europe Candida Infections Drugs Sales Volume Market Share, 2022 VS 2029

Figure 58. By Application, Europe Candida Infections Drugs Sales Volume Market Share, 2022 VS 2029

Figure 59. China Candida Infections Drugs Sales Volume, 2019-2030, (K Units)

Figure 60. By Company, China Candida Infections Drugs Market Share, 2022

Figure 61. By Type, China Candida Infections Drugs Sales Volume Market Share, 2022 VS 2029

Figure 62. By Application, China Candida Infections Drugs Sales Volume Market Share, 2022 VS 2029

Figure 63. Japan Candida Infections Drugs Sales Volume, 2019-2030, (K Units)

Figure 64. By Company, Japan Candida Infections Drugs Market Share, 2022

Figure 65. By Type, Japan Candida Infections Drugs Sales Volume Market Share, 2022 VS 2029

Figure 66. By Application, Japan Candida Infections Drugs Sales Volume Market Share, 2022 VS 2029

Figure 67. South Korea Candida Infections Drugs Sales Volume, 2019-2030, (K Units)

Figure 68. By Company, South Korea Candida Infections Drugs Market Share, 2022

Figure 69. By Type, South Korea Candida Infections Drugs Sales Volume Market Share, 2022 VS 2029

Figure 70. By Application, South Korea Candida Infections Drugs Sales Volume Market Share, 2022 VS 2029

Figure 71. Southeast Asia Candida Infections Drugs Sales Volume, 2019-2030, (K Units)

Figure 72. By Company, Southeast Asia Candida Infections Drugs Market Share, 2022

Figure 73. By Type, Southeast Asia Candida Infections Drugs Sales Volume Market Share, 2022 VS 2029

Figure 74. By Application, Southeast Asia Candida Infections Drugs Sales Volume Market Share, 2022 VS 2029

Figure 75. India Candida Infections Drugs Sales Volume, 2019-2030, (K Units)

Figure 76. By Company, India Candida Infections Drugs Market Share, 2022

Figure 77. By Type, India Candida Infections Drugs Sales Volume Market Share, 2022 VS 2029

Figure 78. By Application, India Candida Infections Drugs Sales Volume Market Share, 2022 VS 2029

Figure 79. Middle East & Asia Candida Infections Drugs Sales Volume, 2019-2030, (K Units)

Figure 80. By Company, Middle East & Asia Candida Infections Drugs Market Share, 2022

Figure 81. By Type, Middle East & Asia Candida Infections Drugs Sales Volume Market Share, 2022 VS 2029

Figure 82. By Application, Middle East & Asia Candida Infections Drugs Sales Volume Market Share, 2022 VS 2029

Figure 83. Research Methodology

Figure 84. Breakdown of Primary Interviews

Figure 85. Bottom-up Approaches

Figure 86. Top-down Approaches